{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:41:19Z","timestamp":1792712479776,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.yjmcc.2016.10.011","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T18:16:02Z","timestamp":1477332962000},"page":"145-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload"],"prefix":"10.1016","volume":"101","author":[{"given":"Nadine","family":"Beetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Rommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Schnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Lother","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa Beatriz","family":"Monroy-Ordonez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Preissl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gilsbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Melchior-Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Rylski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedhelm","family":"Beyersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Stiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yjmcc.2016.10.011_bb0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: mechanisms: part 1 of 2","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.yjmcc.2016.10.011_bb0010","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCULATIONAHA.113.001879","article-title":"Pathological ventricular remodeling: therapies: part 2 of 2","volume":"128","author":"Xie","year":"2013","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.yjmcc.2016.10.011_bb0015","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2016.10.011_bb0020","doi-asserted-by":"crossref","unstructured":"J.N. Cohn, G. Tognoni, I. Valsartan Heart Failure Trial, A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure, N. Engl. J. Med. 345(23) (2001) 1667\u20131675.","DOI":"10.1056\/NEJMoa010713"},{"issue":"10","key":"10.1016\/j.yjmcc.2016.10.011_bb0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.yjmcc.2016.10.011_bb0030","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.yjmcc.2016.10.011_bb0035","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJM199811193392107","article-title":"Implantable left ventricular assist devices","volume":"339","author":"Goldstein","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.yjmcc.2016.10.011_bb0040","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.yjmcc.2016.10.011_bb0045","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa053063","article-title":"Left ventricular assist device and drug therapy for the reversal of heart failure","volume":"355","author":"Birks","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2016.10.011_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.carpath.2010.01.011","article-title":"Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device","volume":"20","author":"Segura","year":"2011","journal-title":"Cardiovasc. Pathol."},{"issue":"19","key":"10.1016\/j.yjmcc.2016.10.011_bb0055","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1111\/j.1742-4658.2010.07796.x","article-title":"Proteoglycans in health and disease: emerging concepts and future directions","volume":"277","author":"Iozzo","year":"2010","journal-title":"FEBS J."},{"issue":"19","key":"10.1016\/j.yjmcc.2016.10.011_bb0060","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1111\/j.1742-4658.2010.07800.x","article-title":"Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting","volume":"277","author":"Theocharis","year":"2010","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.yjmcc.2016.10.011_bb0065","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/febs.12136","article-title":"The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly","volume":"280","author":"Chen","year":"2013","journal-title":"FEBS J."},{"issue":"7","key":"10.1016\/j.yjmcc.2016.10.011_bb0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1096\/fj.01-0848com","article-title":"Abnormal collagen fibrils in tendons of biglycan\/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis","volume":"16","author":"Ameye","year":"2002","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.yjmcc.2016.10.011_bb0075","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.107.714147","article-title":"Biglycan is required for adaptive remodeling after myocardial infarction","volume":"117","author":"Westermann","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2016.10.011_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/1746","article-title":"Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice","volume":"20","author":"Xu","year":"1998","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.yjmcc.2016.10.011_bb0085","first-page":"3597","article-title":"Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice","volume":"119","author":"Beetz","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2016.10.011_bb0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuropharm.2011.02.015","article-title":"Cardiovascular effects of chronic treatment with a beta2-adrenoceptor agonist relieving neuropathic pain in mice","volume":"61","author":"Choucair-Jaafar","year":"2011","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.yjmcc.2016.10.011_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00395-005-0546-3","article-title":"Serial high resolution 3D-MRI after aortic banding in mice: band internalization is a source of variability in the hypertrophic response","volume":"101","author":"Lygate","year":"2006","journal-title":"Basic Res. Cardiol."},{"issue":"9","key":"10.1016\/j.yjmcc.2016.10.011_bb0100","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1038\/jid.2014.69","article-title":"Altered MCM protein levels and autophagic flux in aged and systemic sclerosis dermal fibroblasts","volume":"134","author":"Dumit","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.yjmcc.2016.10.011_bb0105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cardiores.2007.05.017","article-title":"Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction","volume":"75","author":"Gilsbach","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2016.10.011_bb0110","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvq014","article-title":"Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload","volume":"86","author":"Gilsbach","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2016.10.011_bb0115","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.yjmcc.2016.10.011_bb0120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yjmcc.2016.10.011_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.10.011_bb0130","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1038\/ncomms6288","article-title":"Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease","volume":"5","author":"Gilsbach","year":"2014","journal-title":"Nat. Commun."},{"issue":"7414","key":"10.1016\/j.yjmcc.2016.10.011_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Consortium","year":"2012","journal-title":"Nature"},{"issue":"7409","key":"10.1016\/j.yjmcc.2016.10.011_bb0140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11243","article-title":"A map of the cis-regulatory sequences in the mouse genome","volume":"488","author":"Shen","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.yjmcc.2016.10.011_bb0145","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/ATVBAHA.115.306973","article-title":"Loss of biglycan enhances thrombin generation in Apolipoprotein E-deficient mice: implications for inflammation and atherosclerosis","volume":"36","author":"Grandoch","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.yjmcc.2016.10.011_bb0150","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.yjmcc.2016.10.011_bb0155","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1172\/JCI31240","article-title":"Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity","volume":"117","author":"Kuwahara","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.yjmcc.2016.10.011_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00395-009-0046-y","article-title":"FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA\/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK","volume":"105","author":"Chorianopoulos","year":"2010","journal-title":"Basic Res. Cardiol."},{"issue":"13","key":"10.1016\/j.yjmcc.2016.10.011_bb0165","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2016.10.011_bb0170","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCRESAHA.114.302819","article-title":"Dynamic changes in myocardial matrix and relevance to disease: translational perspectives","volume":"114","author":"Li","year":"2014","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.yjmcc.2016.10.011_bb0175","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone","volume":"26","author":"Brilla","year":"1994","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2016.10.011_bb0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCRESAHA.113.301413","article-title":"Molecular changes after left ventricular assist device support for heart failure","volume":"113","author":"Birks","year":"2013","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2016.10.011_bb0185","doi-asserted-by":"crossref","first-page":"H2702","DOI":"10.1152\/ajpheart.00836.2004","article-title":"Regression of pressure overload-induced left ventricular hypertrophy in mice","volume":"288","author":"Gao","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2016.10.011_bb0190","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.athoracsur.2009.07.038","article-title":"Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart","volume":"88","author":"Stansfield","year":"2009","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.yjmcc.2016.10.011_bb0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1053-2498(00)00321-1","article-title":"Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support","volume":"20","author":"Bruckner","year":"2001","journal-title":"J. Heart Lung Transplant."},{"issue":"6","key":"10.1016\/j.yjmcc.2016.10.011_bb0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.healun.2003.06.006","article-title":"Role of mast cells and their mediators in failing myocardium under mechanical ventricular support","volume":"23","author":"Akgul","year":"2004","journal-title":"The Journal of Heart and Lung Transplantation"},{"issue":"3","key":"10.1016\/j.yjmcc.2016.10.011_bb0205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.104.515106","article-title":"Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness","volume":"112","author":"Klotz","year":"2005","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.yjmcc.2016.10.011_bb0210","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.healun.2006.05.011","article-title":"Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern","volume":"25","author":"Bruggink","year":"2006","journal-title":"The Journal of Heart and Lung Transplantation"},{"issue":"10","key":"10.1016\/j.yjmcc.2016.10.011_bb0215","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/hc3501.095215","article-title":"Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2016.10.011_bb0220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cardiores.2003.08.017","article-title":"Induction of myocardial biglycan in heart failure in rats\u2013an extracellular matrix component targeted by AT(1) receptor antagonism","volume":"60","author":"Ahmed","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2016.10.011_bb0225","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.cardiores.2003.08.009","article-title":"Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro","volume":"60","author":"Tiede","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.yjmcc.2016.10.011_bb0230","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1369\/0022155412456380","article-title":"Biglycan: a multivalent proteoglycan providing structure and signals","volume":"60","author":"Nastase","year":"2012","journal-title":"J. Histochem. Cytochem."},{"issue":"7","key":"10.1016\/j.yjmcc.2016.10.011_bb0235","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"19","key":"10.1016\/j.yjmcc.2016.10.011_bb0240","doi-asserted-by":"crossref","first-page":"17365","DOI":"10.1074\/jbc.M110.192682","article-title":"Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype","volume":"286","author":"Melchior-Becker","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.10.011_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.molonc.2016.08.002","article-title":"Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway","author":"Hu","year":"2016","journal-title":"Mol. Oncol."},{"issue":"12","key":"10.1016\/j.yjmcc.2016.10.011_bb0250","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1172\/JCI42213","article-title":"The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis","volume":"120","author":"Moreth","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"36","key":"10.1016\/j.yjmcc.2016.10.011_bb0255","doi-asserted-by":"crossref","first-page":"24035","DOI":"10.1074\/jbc.M109.014266","article-title":"Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors","volume":"284","author":"Babelova","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.10.011_bb0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.matbio.2014.01.010","article-title":"Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury","volume":"35","author":"Moreth","year":"2014","journal-title":"Matrix Biol."},{"issue":"11","key":"10.1016\/j.yjmcc.2016.10.011_bb0265","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4161\/cc.20316","article-title":"Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation","volume":"11","author":"Moreth","year":"2012","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.yjmcc.2016.10.011_bb0270","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1172\/JCI23755","article-title":"The matrix component biglycan is proinflammatory and signals through toll-like receptors 4 and 2 in macrophages","volume":"115","author":"Schaefer","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"15","key":"10.1016\/j.yjmcc.2016.10.011_bb0275","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/CIRCULATIONAHA.108.837286","article-title":"A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure","volume":"119","author":"Jain","year":"2009","journal-title":"Circulation"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282816303881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282816303881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T08:55:56Z","timestamp":1536310556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282816303881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":55,"alternative-id":["S0022282816303881"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.10.011","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}